Daulong, Markclent .

HRN: 23-00-07  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2023
AMPICILLIN 250MG (VIAL)
05/07/2023
05/13/2023
IV
100
Q12
SEPSIS NEONATARUM
Waiting Final Action 
05/07/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
05/07/2023
05/13/2023
IV
9
Q36 Hrs
Sepsis
Waiting Final Action 
05/20/2023
CEFOTAXIME 500MG (VIAL)
05/20/2023
05/27/2023
IVTT
95mg
Q6
Psnb
Waiting Final Action 
05/20/2023
CEFOTAXIME 500MG (VIAL)
05/20/2023
05/27/2023
IVTT
95mg
Q6
T/C RDS OF PREMATURITY
Waiting Final Action 
05/27/2023
CEFTAZIDIME 1GM (VIAL)
05/27/2023
06/04/2023
IVTT
60mg
Q8h
Sepsis Neonatorum
Checking Final Appropriateness 
05/27/2023
OXACILLIN 500MG (VIAL)
05/27/2023
06/03/2023
IVTT
100mg
Q12
Sepsis Neonatorum
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: